Ciclesonide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01410 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 42 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | atopic eczema | KG + DL |
| 2 | 2-hydroxyethyl methacrylate sensitization | KG + DL |
| 3 | dermatitis, atopic | KG + DL |
| 4 | bronchitis | KG + DL |
| 5 | contact dermatitis | KG + DL |
| 6 | asthma-related traits, susceptibility to | KG + DL |
| 7 | phototoxic dermatitis | KG + DL |
| 8 | occupational dermatitis | KG + DL |
| 9 | seborrheic dermatitis | KG + DL |
| 10 | polyp of vocal cord | KG + DL |
| 11 | polyp of middle ear | KG + DL |
| 12 | fibroepithelial polyp | KG + DL |
| 13 | neoplastic polyp | KG + DL |
| 14 | polyp of frontal sinus | KG + DL |
| 15 | polyp of external auditory canal | KG + DL |
| 16 | polyp of vulva | KG + DL |
| 17 | uterine polyp | KG + DL |
| 18 | polyp of ureter | KG + DL |
| 19 | epulis | KG + DL |
| 20 | atopic dermatitis | KG + DL |
| 21 | obstructive lung disease | KG + DL |
| 22 | dermatitis | KG + DL |
| 23 | ichthyosis hystrix gravior | KG + DL |
| 24 | ichthyosis vulgaris | KG + DL |
| 25 | acrodermatitis chronica atrophicans | KG + DL |
| 26 | Stankiewicz-Isidor syndrome | KG + DL |
| 27 | white sponge nevus | KG + DL |
| 28 | acne keloid | KG + DL |
| 29 | seborrheic keratosis | KG + DL |
| 30 | neonatal dermatomyositis | KG + DL |
| 31 | vulvar inverted follicular keratosis | KG + DL |
| 32 | hydroa vacciniforme, familial | KG + DL |
| 33 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 34 | exanthem (disease) | KG + DL |
| 35 | amyopathic dermatomyositis | KG + DL |
| 36 | nasal cavity polyp | KG + DL |
| 37 | primary cutaneous T-cell lymphoma | KG + DL |
| 38 | respiratory malformation | KG + DL |
| 39 | bronchial neoplasm (disease) | KG + DL |
| 40 | Crohn’s colitis | KG + DL |
| 41 | pulmonary emphysema | KG + DL |
| 42 | Rienhoff syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.